AI in Histopathology Explorer
Summary
Analysis
Overview
Models
Reproducibility
Authorship
Foundation Models
Performance
Task
Models
Implementaion
Tools
Paper search
Intelligent explorer
Design assistant
Network tool
Help
Terminology
Submit paper details
Code
Contact Us
About Us
Intelligent research explorer
Article search
( Specify one or more of the following parameters for your study. )
Visual Insights
Cancer type
Not specified
Bladder cancer
Brain cancer
Breast cancer
Cervical cancer
Colorectal cancer
Endometrial cancer
Esophagus cancer
Gastric cancer
Head & neck cancer others
Hematologic cancer
Kidney cancer
Liver cancer
Lung cancer
Metastasis cancer
Oral cancer
Other cancers
Ovarian cancer
Pancreatic cancer
Prostate cancer
Skin cancer
Thyroid cancer
Class
Not specified
Benign (170)
Normal (128)
Malignant (112)
Metastasis (50)
Lung Adenocarcinoma (LUAD) (42)
Lung Squamous Cell Carcinoma (LUSC) (42)
Microsatellite Instability (MSI) (36)
Abnormal (32)
Microsatellite Stability (MSS) (31)
In situ Carcinoma (28)
Grade 2 (26)
Grade 3 (26)
Survival (26)
Invasive (25)
Grade 1 (24)
Cancer (24)
HER2 (22)
Gleason Grade 3 (20)
Recurrence risk (18)
Invasive Ductal Carcinoma (IDC) (18)
Tumor (17)
Gleason Grade 4 (16)
Lymphocytes (LYM) (15)
Low-grade Squamous Intraepithelial Lesion (LSIL) (14)
Gleason Grade 5 (14)
Superficial-Intermediate (13)
Parabasal (13)
Koilocytotic (13)
Dysketarotic (13)
Metaplastic (13)
Image Background (BACK) (13)
Muscle (MUS) (13)
High-grade Squamous Intraepithelial Lesion (12)
Negative for Intraepithelial Lesion or Malignancy (NILM) (12)
Mucus (MUC) (12)
Squamous cell carcinoma (11)
Non-Invasive Ductal Carcinoma (IDC) (11)
Colon Adenocarcinoma (ADC) (11)
Adipose (11)
Cancer-associated Stroma (STR) (10)
Colorectal adenocarcinoma epithelium (TUM) (10)
Debris (10)
Grade 0 (10)
Grade 4 (9)
Cervical Intraepithelial Neoplasia (9)
Tumor proportion (9)
Non-cancer (9)
Ki67 (9)
TP53 (8)
Small Cell Lung Cancer (8)
BRAF (8)
Lymphoid Leukemia (8)
ER (8)
Superficial Squamous Epithelial (7)
Intermediate Squamous Epithelial (7)
Columnar Epithelial (7)
Mild Dysplasia (7)
Moderate Dysplasia (7)
Severe Dysplasia (7)
Tumour-Infiltrating Lymphocytes (7)
Acute Myeloid Leukemia (7)
Healthy (7)
Atypical Squamous Cells (6)
Adenocarcinoma (6)
Stroma (6)
HPV (6)
Low-Grade Glioma (LGG) (6)
Glioblastoma (6)
Non-tumor (6)
Epstein-Barr Virus (6)
Basal Cell Carcinoma (6)
Necrosis (6)
Clear Cell Renal Cell Carcinoma (6)
Mitosis (6)
Fat (6)
PD-L1 (6)
Epithelial (5)
Oral Squamous Cell Carcinoma (OSCC) (5)
High-Grade Glioma (5)
Papillary Renal Cell Carcinoma (5)
Non-mitosis (5)
Negative (5)
Homologous Recombination Deficiency (HRD) (4)
Neoplastic (4)
FGFR (4)
Ductal Carcinoma In Situ (4)
Others (4)
Large Cell Neuroendocrine Carcinoma (LCNEC) (4)
Good prognosis (4)
Poor prognosis (4)
Non-Basal Cell Carcinoma (BCC) (4)
Hepatocellular Carcinoma (4)
Acute Promyelocytic Leukemia (4)
Blast cell (4)
Chronic Lymphoblastic/Lymphocytic/Lymphoid Leukemia (CLL) (4)
Circulating Tumor Cells (CTCs) (4)
Invasive Lobular Carcinoma (ILC) (4)
PR (4)
Acinar (4)
Lepidic (4)
Solid (4)
Positive (4)
Homologous Recombination Proficient (HRP) (3)
Non-neoplastic (3)
Non-responder (3)
Responder (3)
EGFR (3)
KRAS (3)
Helicobacter pylori (3)
No Tumour-Infiltrating Lymphocytes (TILs) (3)
Non-Glioblastoma (GBM) (3)
CMS1 (3)
CMS2 (3)
Pancreatic Ductal Adenocarcinoma (3)
Diffuse Large B-Cell Lymphoma (DLBCL) (3)
Non-blast cell (3)
Follicular Lymphoma (3)
Myelodysplastic Syndromes (MDS) (3)
Papillary Thyroid Carcinoma (3)
Parenchyma (3)
Gleason Grade 1 (3)
Gleason Grade 2 (3)
Astrocytoma (3)
Oligodendroglioma (3)
Isolated Tumor Cells (ITCs) (3)
Micropapillary (3)
Papillary (3)
Dysplasia (3)
Other (3)
Immune cells (3)
High Risk (3)
Low Risk (3)
Immune Subtypes (3)
Atypical Glandular Cells (2)
BRCA (2)
White Blood Cells (2)
Low-Grade Serous Carcinoma (LGSC) (2)
Mucinous Carcinoma (MUC) (2)
Mismatch Repair (MMR) (2)
Poorly differentiated Adenocarcinoma (ADC) (2)
Five types of gene mutant (2)
Five types of gene non-mutant (2)
ALK (2)
Circulating Genetically Abnormal Cells (2)
Deletion cell (2)
Gain cell (2)
Mesothelioma (2)
Non-pathological Complete Response (pCR) (2)
Pathological Complete Response (pCR) (2)
Chromosomal Instability (2)
CMS3 (2)
CMS4 (2)
Tertiary Lymphoid Structures (2)
BAP1 (2)
Sentinel Node (2)
Microvascular Invasion (MVI) (2)
Cholangiocarcinoma (2)
Homologous Recombination Deficiency (HRD) high (2)
Homologous Recombination Deficiency (HRD) low (2)
Non-Acute Promyelocytic Leukemia (APL) (2)
Chronic Myelogenous/Myeloid/Myelocytic Leukemia (CML) (2)
Aplastic Anemia (2)
Multiple Myeloma (MM) (2)
Cutaneous Squamous Cell Carcinoma (cSCC) (2)
Non-Circulating Tumor Cells (CTCs) (2)
Non-Papillary Thyroid Carcinoma (PTC) (2)
Head and Neck Squamous Cell Carcinoma (HNSCC) (2)
Chromophobe Renal Cell Carcinoma (2)
Urothelial Carcinoma (2)
Invasive Breast Cancer (BCa) (2)
Non-invasive Breast Cancer (BCa) (2)
IDH (2)
Control (2)
Adenoma (2)
Follicular Thyroid Carcinoma (2)
Lymph node (2)
Meningioma (2)
Pituitary adenoma (2)
Schwannoma (2)
Fibroblast (2)
Glioma (2)
Non-recurrence (2)
High-grade Squamous Intraepithelial Lesion (HSIL) (2)
Small Cell Lung Cancer (SCLC) (2)
Non-Small Cell Lung Cancer(NSCLC) (2)
Stromal (2)
Debris (DEB) (2)
Normal colon mucosa (NORM) (2)
Grade 5 (2)
Cellular infiltration (2)
Kidney Chromophobe Renal Cell Carcinoma (KICH) (2)
Kidney Renal Clear Cell Carcinoma (KIRC) (2)
Mutated (2)
Adenocarcinoma (ADC) (2)
Squamous Cell Carcinoma (SCC) (2)
Recurrence (2)
Bengin (2)
Cold tumor (2)
Hot tumor (2)
In situ carcinoma (2)
Invasive carcinoma (2)
Glioma grades (2)
Actinomyces (Actin) (1)
Candida (Cand) (1)
Flora (1)
Herps (1)
Trichomonas (Trich) (1)
Endocervical Adenocarcinoma (ADC) (1)
Endometroid adenocarcinoma (1)
Serous endometrial adenocarcinoma (1)
Michigan Cancer Foundation-7 (MCF-7) (1)
Precancer (1)
Endometrial Intraepithelial Neoplasia (1)
Non-Endometrial Intraepithelial Neoplasia (EIN) (1)
Hyperplasia without atypia (1)
Clear Cell Ovarian Carcinoma (1)
Endometrioid (1)
High-Grade Serous Carcinoma (1)
POLE (1)
Long-term survivors (1)
Short-term survivors (1)
Neutrophils (1)
Columnar Cell Lesion (1)
Usual Ductal Hyperplasia (UDH) (1)
RB1 (1)
Breast cancer cells (1)
Gastric cancer cells (1)
Pancreatic cancer cells (1)
Non-Transitional Mesothelioma (TM) (1)
Transitional Mesothelioma (TM) (1)
Interstitial Pneumonia (1)
Non-Interstitial Pneumonia (UIP) (1)
PDGFRB (1)
ROS1 fusion (1)
Atypical Carcinoid (1)
Primary site: breast (1)
Primary site: gastric (1)
Primary site: lung carcinomas (1)
Organizing Pneumonia (OP) (1)
Pulmonary Tuberculosis (PTB) (1)
STK11 (1)
Progression Free Interval (1)
Non-Lung Squamous Cell Carcinoma (LUSC) (1)
Molecular subtypes A (1)
Molecular subtypes B (1)
Molecular subtypes C (1)
Molecular subtypes D (1)
Molecular subtypes E (1)
APC (1)
Marsh (1)
Genomically Stable (1)
Differentiated ADC (1)
Nonneoplastic lesion (1)
Protein expression phenotype (1)
P53 (1)
DTSR-high (> 50% stroma) (deep learning tumor-stroma ratio) (1)
DTSR-low (<= 50% stroma) (deep learning tumor-stroma ratio) (1)
Mild multifocal (1)
Non-brisk (mild or moderate focal or mild diffuse TIL infiltrate) (1)
Cutaneous mast cell grade 1 (1)
Cutaneous mast cell grade 2 (1)
Cutaneous mast cell grade 3 (1)
SOX10 (1)
Gene Expression Phenotype (1)
Age (1)
High sub-type liver HCC tumor (1)
Low sub-type liver HCC tumor (1)
Medium sub-type liver HCC tumor (1)
Pancreatic Intraepithelial Neoplasia (1)
Conventional Pancreatic Ductal Adenocarcinoma (cPDAC) (1)
Intraductal Papillary Mucinous Carcinoma (IPMC) (1)
Vater Adenocarcinoma (AVAC) (1)
Chronic Pancreatitis (1)
Myeloma (1)
Non-myeloma (1)
Burkitt Lymphoma (1)
Intestinal T-cell Lymphoma (1)
Monomorphic Epitheliotropic Intestinal T-cell Lymphoma (1)
Large Cell Transformation (1)
Reactive Lymphoid (RL) (1)
Normal cell (1)
Mycosis Fungoides (MF) (1)
Non-Mycosis Fungoides (MF) (1)
CEBPA (1)
Non-Diffuse Large B-Cell Lymphoma (DLBCL) (1)
Decreased granules (DG) 0 (1)
Decreased granules (DG) 1-3 (1)
Follicular Hyperplasia (1)
NPM1 (1)
Leukemia (1)
Non-APL Acute Myelogenous/Myeloid/Myelocytic Leukemia (AML) (1)
Essential Thrombocythemia (ET) (1)
Polycythemia Vera (1)
Primary myelofibrosis (1)
Acute Hypoxia (AH) (1)
Chronic Hypoxia (1)
Normoxia (1)
No Whole-Genome Doubling (WGD) (1)
Whole-Genome Doubling (WGD) (1)
Urothelial abnormal (1)
Urothelial normal (1)
Esophageal Adenocarcinoma High-Grade Dysplasia (HGD) (1)
Non-dysplastic Barrett's Esophagus (1)
Atypical Urothelial Cells (1)
High-Grade Urothelial Carcinoma (1)
Low-Grade Urothelial Neoplasm (LGUN) (1)
Renal Cancer (1)
Sebaceous Carcinoma (SC) (1)
Blood cells (1)
Cluster (1)
Bowen’s Disease (1)
Seborrheic Keratosis (1)
Alveolar Rhabdomyosarcoma (1)
Embryonal Rhabdomyosarcoma (1)
PBRM1 (1)
SETD2 (1)
Dedifferentiated Liposarcoma (1)
Leiomyosarcomas (LMS) (1)
Myxofibrosarcoma (MFS) (1)
Synovial Sarcoma (1)
Undifferentiated Pleomorphic Sarcoma (UPS) (1)
High Oncotype DX (1)
Intermediate Oncotype DX (ODX) (1)
Low Oncotype DX (ODX) (1)
Low Oncotype DX (ODX) and low Bloom-Richardson (BR) grade (1)
Lobular Carcinoma In Situ (LCIS) (1)
Grade 4 cribriform (1)
Grade 4 fused (1)
Grade 4 glomeruloid (1)
Grade 4 ill defined (1)
Non-labelled tissue (1)
Basal-like (1)
Luminal A (1)
Luminal B (1)
Gleason Grade >=4 (1)
Non-atypical (1)
Atypical ductal hyperplasia (1)
Non-proliferative changes only (1)
Prolifeerative changes (1)
Gleason Grade 4 + Gleason Grade 5 (1)
Invasive Carcinoma of No Special Type (IC-NST) (1)
No Invasive Carcinoma of No Special Type (IC-NST) (1)
Non-neoplastic Pathological Brain tissue (1)
ERG (1)
Chromophobe renal cell carcinoma (KICH) (1)
Clear cell renal cell carcinoma (KIRC) (1)
Papillary renal cell carcinoma (KIRP) (1)
Luminal breast cancer (1)
Non-luminal breast cancer (1)
Anemia (1)
Adenomatous goiter (1)
Medullary Thyroid Carcinoma (MTC) (1)
Normal thyroid gland (1)
Collagen Signatures (1)
Uterine Corpus Endometrial Carcinoma (UCEC) (1)
Spread Through Air Space (1)
High-Grade Dysplasia (1)
Low Risk Lesions (LRL) (1)
Renal oncocytoma (1)
AR (1)
Endometrial Adenocarcinoma (1)
Endometrial Polyp (1)
Endometrial hyperplasia (EH) (1)
Non-Chronic Lymphoblastic/Lymphocytic/Lymphoid Leukemia (CLL) (1)
GLUT-1 (1)
Epidermis (1)
Lymphoma (L) (1)
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) (1)
Intracranial Germinoma (IG) (1)
Normal control (1)
Mantle Cell Lymphoma (MCL) (1)
Tumor Regression Grade 0 (1)
Tumor Regression Grade 1/2 (1)
Tumor Regression Grade 3 (1)
Peripheral Blood Mononuclear Cell (PBMC) (1)
Muscularis Propria (MP) (1)
Non-Muscularis Propria (MP) (1)
Nerve tissue (1)
Non-nerve tissue (1)
High-grade (1)
Low-grade (1)
Inflammatory (1)
Miscellaneous (1)
Mild (1)
Severe (1)
Typical large-bowel biopsies (1)
Latent membrane protein (LMP) 1 negative (1)
Latent membrane protein (LMP) 1 positive (1)
Macrophages (1)
Chemo-sensitivity (1)
High drug sensitivity (1)
Low drug sensitivity (1)
FOXP3 (1)
Gleason Grade 1-5 (1)
Gleason Grade >=6 (1)
Colorectal carcinoma (1)
Silva Pattern (1)
Multiple myeloma (1)
Other hematological malignancies (1)
Non-invasive (1)
Double expressor negative (1)
Double expressor positive (1)
Non-adenoma (1)
High risk (1)
Low risk (1)
Blood and lymphatic system (1)
Digestive system (1)
Female reproductive system (1)
Respiratory system (1)
High Ovarian Cancer Digital Pathology Index (OCDPI) (1)
Low Ovarian Cancer Digital Pathology Index (OCDPI) (1)
Microvascular invasion phenotypes (1)
Biopsy and endoscopic resection (1)
TMB (1)
Nuclei (1)
Primary CNS Lymphoma (1)
Hematopoietic tissue (1)
IgG4-ROD (1)
Orbital MALT lymphoma (1)
Non-viable tumor (1)
Complete Response to Radiotherapy (1)
No Complete Response to Radiotherapy (1)
Neurofibroma (1)
Perineurioma (1)
Schwannoma (1)
Amplified (1)
Non-amplified (1)
High-Grade Dysplasia (HGD) (1)
Low-Grade Dysplasia (LGD) (1)
Nondysplastic Barret Esophagus (NDBE) (1)
Microsatellite Instability (1)
Necrosis or Stroma (1)
Atypical Glandular Cells (AGC) (1)
Atypical Squamous Cells of Undetermined Significance (ASC-US) (1)
Normal Cells (1)
Abnormal Cells (1)
Epithelial Cell Abnormalities Squamous Cells (ECA-SC) (1)
Epithelial Cell Abnormalities Glandular Cells (ECA-GC) (1)
Organisms (1)
Nondysplastic Barrett esophagus (NDBE) (1)
Melanocytic Density (1)
Nasopharyngeal Carcinoma (1)
Non-Nasopharyngeal Carcinoma (1)
Adenocarcinoma In Situ (AIS) (1)
Complex Gland (1)
Micropappilary (1)
Pappilary (1)
Clean (1)
Intramural Invasion (1)
Benign inflamatory dermosis (BIDs) (1)
Mycisis fungoids (MF) (1)
Oncocytic Papillary Adenocarcinoma (OPA) (1)
Non-Oncocytic Papillary Adenocarcinoma (N-OPA) (1)
Tumor cells (1)
Stromal cells (1)
Pleomorphic adenoma (PA) (1)
Myoepithelioma (MYO) (1)
Warthin tumor (WT) (1)
Basal cell adenoma (BCA) (1)
Oncocytic adenoma (OA) (1)
Cystadenoma (CST) (1)
Mucoepidermoid carcinoma (MEC) (1)
Salivary adenoid cystic carcinoma (SACC) (1)
Normal (Norm) (1)
Ki-67 (1)
Leukocytes (1)
Pollution (1)
Red blood cells (1)
Lymphocytes (1)
Low-immune (1)
Mid-immune (1)
Diploid (1)
Aneuploid (1)
Neutrophil (1)
Eosinophil (1)
Basophil (1)
Lymphocyte (1)
Monocyte (1)
Immature granulocyte (1)
Erythroblast (1)
Platelet (1)
Normal mucosa (NORM) (1)
Stroma (STR) (1)
Adipose tissue (ADI) (1)
Normal lymph node tissue (1)
Sessile Serrated Adenoma (SSA) (1)
Hyperplastic Polyp (HP) (1)
CDH1 (1)
PIK3CA (1)
Dysplastic Epithelium (1)
OED transformation risk (1)
MLH1 (1)
PMS2 (1)
Mutation Density (1)
Microsatellite Instability (MSI) high (1)
Cervical Intraepithelial Neoplasia (CIN) (1)
Genome Stable (GS) (1)
Pleomorphism (1)
Adipose (ADI) (1)
Cancer-associated Stroma (STR) (1)
Colorectal adenocarcinoma epithelium (TUM) (1)
Non-dysplasia (1)
IFTA (1)
ARM (1)
Fatty change (1)
Hypertrophy (1)
Increased mitosis (1)
Proliferation (1)
Extramedullary hematopoiesis (1)
And Kidney Renal Papillary Cell Carcinoma (KIRP) (1)
Lymphocytes (LYSM) (1)
Wild Type (1)
Tumour tissue (T) (1)
Nontumour tissue (NT) (1)
Lymph node (LN) (1)
Biopsy and endoscopic resection (BE) (1)
Immunohistochemistry (IHC) (1)
Tissue microarray (TMA) (1)
['Adipose (ADI) (1)
Background (BACK) (1)
Debris (DEB) (1)
Lymphocytes (LYM) (1)
Mucus (MUC) (1)
Smooth muscle (MUS) (1)
Normal colon mucosa (NORM) (1)
Cancer-associated stroma (STR) (1)
Colorectal adenocarcinoma epithelium (TUM)'] (1)
Consensus Molecular Subtypes (CMS) (1)
Chromophobe (1)
Renal papillary cell carcinoma (RPCC) (1)
Kidney Renal Papillary Cell Carcinoma (KIRP) (1)
Favorable (1)
Poor (1)
Present (1)
Absence (1)
Liver Hepatocellular Carcinoma (HCC) (1)
Lung Squamous Cell Carcinoma (LSCC) (1)
Renal Clear Cell Carcinoma (RCC) (1)
Papillary Thyroid Carcinoma (PTC) (1)
High-Grade Serous Carcinoma (HGSC) (1)
Endometrioid Carcinoma (ENC) (1)
Clear Cell Carcinoma (CCC) (1)
Stage I (1)
Stage II (1)
Stage III (1)
Stage IV (1)
Stage Not Available (1)
Serous Borderline Ovarian Tumor (SBOT) (1)
High-grade Serous Ovarian Cancer (HGSOC) (1)
Epithelial Mesenchymal Transition (EMT) (1)
Kirsten Rat Sarcoma viral oncogene homolog (KRAS) (1)
Tumor-Stroma Reaction (TSR) (1)
Serous (1)
Mucinous (1)
Endometroid (1)
Clear Cell (1)
Non-Cancerous (1)
No-recurrence (1)
Effective (1)
Invalid (1)
Sensitive (responder) (1)
Refractory (non-responder) (1)
Favorable response (1)
Poor response (1)
Atypical (1)
Ductal carcinoma in situ (DCIS) (1)
Not Mutated (1)
Carcinoid (1)
Normal cells (1)
Non-Squamous Cell Carcinoma (NSCC) (1)
Small Cell Carcinoma (1)
High-grade dysplasia (HGD) (1)
Low-grade dysplasia (LGD) (1)
Nondysplastic Barrett’s esophagus (NDBE) (1)
Dysplastic (1)
B-cell lymphoma (1)
T-cell lymphoma (1)
Basal (1)
Luminal (1)
Glandular (1)
Pancreatic Ductal Adenocarcinoma (PDAC) (1)
Subtype I (1)
Subtype II (1)
Subtype III (1)
Sebaceous Gland Carcinoma (SGC) (1)
Squamous Cell Carcinoma (SC) (1)
CIN2+ (1)
Melanoma (1)
Nevus (1)
Sjögren's syndrome (1)
Colon Adenocarcinoma (1)
Benign Colonic Tissue (1)
Lung Adenocarcinoma (1)
Lung Squamous Cell Carcinoma (1)
Benign Lung Tissue (1)
Lymph node metastasis (1)
Basaloid cell (1)
Ghost cell (1)
Other cell (1)
Follicular Adenoma (1)
Follicular Thyroid Carcinoma recurrence (1)
Vascular Invasion (1)
Wide Capsular Invasion (1)
Non-invasive Epithelial Superficial Region (1)
Submucosal Invasive Region (1)
Early recurrence (1)
CD8 (1)
CD4 (1)
Tumor aggressiveness grade (1)
M2 macrophage infiltration (1)
Intraepithelial neoplasia (1)
Polyp (1)
M2-subtype tumor-associated macrophage density (1)
Gleason grades (1)
Nondiagnostic (1)
Follicular neoplasm (1)
No recurrence (1)
Adenosis (1)
Fibroadenoma (1)
Phyllodes tumor (1)
Tubular adenoma (1)
Ductal carcinoma (1)
Lobular carcinoma (1)
Mucinous carcinoma (1)
Papillary carcinoma (1)
Benign colon tissue (1)
Colon adenocarcinomas (1)
Intrahepatic Cholangiocarcinoma (1)
Combined Hepatocellular-Cholangiocarcinoma (1)
Relapse (1)
No relapse (1)
Alveoli (1)
Background (1)
ESCC-pathomics signature (1)
MGMT promoter (1)
Odontogenic Keratocyst (OKC) (1)
Orthokeratinized Odontogenic Cyst (OOC) (1)
Gorlin Syndrome (GS) (1)
Tertiary lymphoid structures (TLSs) (1)
Invasive Ductal Carcinoma (1)
Platinum sensitive (1)
Refractory/resistive (1)
Task type
Not specified
Detection
Diagnosis and subtyping
Others
Prognosis
Risk prediction
Segmentation and detection
Survival
Treatment design
Machine learning task
Not specified
Binary classification
Image generation
Multi-class classification
Object detection
Regression
Segmentation
Self supervised
Semi supervised
Unsupervised
Weakly supervised
Data collection technique
Not specified
Cytology
H&E
IHC
Microscopy
Multiplexed imaging
Multiple cohorts
Not specified
Yes
No
Network type
Not specified
Autoencoder
CNN
CNN-Custom
Custom
Generative
Graph-based
Object Detection
Recurrent
Segmentation
Transformer
Weakly supervised
Dataset
Not specified
ALL_IDB
BACH
BCCD
BCSS
BHI
BUSI
BioImaging2015
BreCaHAD
BreakHis
CAMELYON16
CPM
CPM-17
CPTAC
CRAG
CRC
CRC-TP
CRCHistoPhenotypes
CoNSeP
DACHS
DigestPath
Epi700
GLaS
GasHisDB
GlaS
HER2c
HPA
Herlev
LBC
LC25000
LYON19
LYSTO
MITOS-ATYPIA-14
MITOS2012
MoNuSeg
NCT-CRC-HE-100K
NLCS
NLST
PAIP
PAIP2019
PanNuke
PatchCamelyon
QUASAR
SiPaKMeD
TCGA
TCIA
TUPAC16
Wang et al
animal-dataset
public-set
Data availability
Not specified
Fully available
Not available
Partially available
Upon request
Search option:
Exact Match
Nearest Neighbours-based
Submit
Clear
Distribution of papers by year
Distribution of papers by performance average
Reported quality index parameters among papers
Ranked papers based on similarity and performance
Sort by
Average performance
Publication year
Cancer type
Model type
Data collection technique
Dataset size
Dataset
Resources
Download
Previous
Next
Visual Insights
Cancer type
Not specified
Bladder cancer
Brain cancer
Breast cancer
Cervical cancer
Colorectal cancer
Endometrial cancer
Esophagus cancer
Gastric cancer
Head & neck cancer others
Hematologic cancer
Kidney cancer
Liver cancer
Lung cancer
Metastasis cancer
Oral cancer
Other cancers
Ovarian cancer
Pancreatic cancer
Prostate cancer
Skin cancer
Thyroid cancer
Class
Not specified
Benign
Normal
Malignant
Metastasis
Lung Adenocarcinoma (LUAD)
Lung Squamous Cell Carcinoma (LUSC)
Microsatellite Instability (MSI)
Abnormal
Microsatellite Stability (MSS)
In situ Carcinoma
Grade 2
Grade 3
Survival
Invasive
Grade 1
Cancer
HER2
Gleason Grade 3
Recurrence risk
Invasive Ductal Carcinoma (IDC)
Tumor
Gleason Grade 4
Lymphocytes (LYM)
Low-grade Squamous Intraepithelial Lesion (LSIL)
Gleason Grade 5
Superficial-Intermediate
Parabasal
Koilocytotic
Dysketarotic
Metaplastic
Image Background (BACK)
Muscle (MUS)
High-grade Squamous Intraepithelial Lesion
Negative for Intraepithelial Lesion or Malignancy (NILM)
Mucus (MUC)
Squamous cell carcinoma
Non-Invasive Ductal Carcinoma (IDC)
Colon Adenocarcinoma (ADC)
Adipose
Cancer-associated Stroma (STR)
Colorectal adenocarcinoma epithelium (TUM)
Debris
Grade 0
Grade 4
Cervical Intraepithelial Neoplasia
Tumor proportion
Non-cancer
Ki67
TP53
Small Cell Lung Cancer
BRAF
Lymphoid Leukemia
ER
Superficial Squamous Epithelial
Intermediate Squamous Epithelial
Columnar Epithelial
Mild Dysplasia
Moderate Dysplasia
Severe Dysplasia
Tumour-Infiltrating Lymphocytes
Acute Myeloid Leukemia
Healthy
Atypical Squamous Cells
Adenocarcinoma
Stroma
HPV
Low-Grade Glioma (LGG)
Glioblastoma
Non-tumor
Epstein-Barr Virus
Basal Cell Carcinoma
Necrosis
Clear Cell Renal Cell Carcinoma
Mitosis
Fat
PD-L1
Epithelial
Oral Squamous Cell Carcinoma (OSCC)
High-Grade Glioma
Papillary Renal Cell Carcinoma
Non-mitosis
Negative
Homologous Recombination Deficiency (HRD)
Neoplastic
FGFR
Ductal Carcinoma In Situ
Others
Large Cell Neuroendocrine Carcinoma (LCNEC)
Good prognosis
Poor prognosis
Non-Basal Cell Carcinoma (BCC)
Hepatocellular Carcinoma
Acute Promyelocytic Leukemia
Blast cell
Chronic Lymphoblastic/Lymphocytic/Lymphoid Leukemia (CLL)
Circulating Tumor Cells (CTCs)
Invasive Lobular Carcinoma (ILC)
PR
Acinar
Lepidic
Solid
Positive
Homologous Recombination Proficient (HRP)
Non-neoplastic
Non-responder
Responder
EGFR
KRAS
Helicobacter pylori
No Tumour-Infiltrating Lymphocytes (TILs)
Non-Glioblastoma (GBM)
CMS1
CMS2
Pancreatic Ductal Adenocarcinoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Non-blast cell
Follicular Lymphoma
Myelodysplastic Syndromes (MDS)
Papillary Thyroid Carcinoma
Parenchyma
Gleason Grade 1
Gleason Grade 2
Astrocytoma
Oligodendroglioma
Isolated Tumor Cells (ITCs)
Micropapillary
Papillary
Dysplasia
Other
Immune cells
High Risk
Low Risk
Immune Subtypes
Atypical Glandular Cells
BRCA
White Blood Cells
Low-Grade Serous Carcinoma (LGSC)
Mucinous Carcinoma (MUC)
Mismatch Repair (MMR)
Poorly differentiated Adenocarcinoma (ADC)
Five types of gene mutant
Five types of gene non-mutant
ALK
Circulating Genetically Abnormal Cells
Deletion cell
Gain cell
Mesothelioma
Non-pathological Complete Response (pCR)
Pathological Complete Response (pCR)
Chromosomal Instability
CMS3
CMS4
Tertiary Lymphoid Structures
BAP1
Sentinel Node
Microvascular Invasion (MVI)
Cholangiocarcinoma
Homologous Recombination Deficiency (HRD) high
Homologous Recombination Deficiency (HRD) low
Non-Acute Promyelocytic Leukemia (APL)
Chronic Myelogenous/Myeloid/Myelocytic Leukemia (CML)
Aplastic Anemia
Multiple Myeloma (MM)
Cutaneous Squamous Cell Carcinoma (cSCC)
Non-Circulating Tumor Cells (CTCs)
Non-Papillary Thyroid Carcinoma (PTC)
Head and Neck Squamous Cell Carcinoma (HNSCC)
Chromophobe Renal Cell Carcinoma
Urothelial Carcinoma
Invasive Breast Cancer (BCa)
Non-invasive Breast Cancer (BCa)
IDH
Control
Adenoma
Follicular Thyroid Carcinoma
Lymph node
Meningioma
Pituitary adenoma
Schwannoma
Fibroblast
Glioma
Non-recurrence
High-grade Squamous Intraepithelial Lesion (HSIL)
Small Cell Lung Cancer (SCLC)
Non-Small Cell Lung Cancer(NSCLC)
Stromal
Debris (DEB)
Normal colon mucosa (NORM)
Grade 5
Cellular infiltration
Kidney Chromophobe Renal Cell Carcinoma (KICH)
Kidney Renal Clear Cell Carcinoma (KIRC)
Mutated
Adenocarcinoma (ADC)
Squamous Cell Carcinoma (SCC)
Recurrence
Bengin
Cold tumor
Hot tumor
In situ carcinoma
Invasive carcinoma
Glioma grades
Actinomyces (Actin)
Candida (Cand)
Flora
Herps
Trichomonas (Trich)
Endocervical Adenocarcinoma (ADC)
Endometroid adenocarcinoma
Serous endometrial adenocarcinoma
Michigan Cancer Foundation-7 (MCF-7)
Precancer
Endometrial Intraepithelial Neoplasia
Non-Endometrial Intraepithelial Neoplasia (EIN)
Hyperplasia without atypia
Clear Cell Ovarian Carcinoma
Endometrioid
High-Grade Serous Carcinoma
POLE
Long-term survivors
Short-term survivors
Neutrophils
Columnar Cell Lesion
Usual Ductal Hyperplasia (UDH)
RB1
Breast cancer cells
Gastric cancer cells
Pancreatic cancer cells
Non-Transitional Mesothelioma (TM)
Transitional Mesothelioma (TM)
Interstitial Pneumonia
Non-Interstitial Pneumonia (UIP)
PDGFRB
ROS1 fusion
Atypical Carcinoid
Primary site: breast
Primary site: gastric
Primary site: lung carcinomas
Organizing Pneumonia (OP)
Pulmonary Tuberculosis (PTB)
STK11
Progression Free Interval
Non-Lung Squamous Cell Carcinoma (LUSC)
Molecular subtypes A
Molecular subtypes B
Molecular subtypes C
Molecular subtypes D
Molecular subtypes E
APC
Marsh
Genomically Stable
Differentiated ADC
Nonneoplastic lesion
Protein expression phenotype
P53
DTSR-high (> 50% stroma) (deep learning tumor-stroma ratio)
DTSR-low (<= 50% stroma) (deep learning tumor-stroma ratio)
Mild multifocal
Non-brisk (mild or moderate focal or mild diffuse TIL infiltrate)
Cutaneous mast cell grade 1
Cutaneous mast cell grade 2
Cutaneous mast cell grade 3
SOX10
Gene Expression Phenotype
Age
High sub-type liver HCC tumor
Low sub-type liver HCC tumor
Medium sub-type liver HCC tumor
Pancreatic Intraepithelial Neoplasia
Conventional Pancreatic Ductal Adenocarcinoma (cPDAC)
Intraductal Papillary Mucinous Carcinoma (IPMC)
Vater Adenocarcinoma (AVAC)
Chronic Pancreatitis
Myeloma
Non-myeloma
Burkitt Lymphoma
Intestinal T-cell Lymphoma
Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
Large Cell Transformation
Reactive Lymphoid (RL)
Normal cell
Mycosis Fungoides (MF)
Non-Mycosis Fungoides (MF)
CEBPA
Non-Diffuse Large B-Cell Lymphoma (DLBCL)
Decreased granules (DG) 0
Decreased granules (DG) 1-3
Follicular Hyperplasia
NPM1
Leukemia
Non-APL Acute Myelogenous/Myeloid/Myelocytic Leukemia (AML)
Essential Thrombocythemia (ET)
Polycythemia Vera
Primary myelofibrosis
Acute Hypoxia (AH)
Chronic Hypoxia
Normoxia
No Whole-Genome Doubling (WGD)
Whole-Genome Doubling (WGD)
Urothelial abnormal
Urothelial normal
Esophageal Adenocarcinoma High-Grade Dysplasia (HGD)
Non-dysplastic Barrett's Esophagus
Atypical Urothelial Cells
High-Grade Urothelial Carcinoma
Low-Grade Urothelial Neoplasm (LGUN)
Renal Cancer
Sebaceous Carcinoma (SC)
Blood cells
Cluster
Bowen’s Disease
Seborrheic Keratosis
Alveolar Rhabdomyosarcoma
Embryonal Rhabdomyosarcoma
PBRM1
SETD2
Dedifferentiated Liposarcoma
Leiomyosarcomas (LMS)
Myxofibrosarcoma (MFS)
Synovial Sarcoma
Undifferentiated Pleomorphic Sarcoma (UPS)
High Oncotype DX
Intermediate Oncotype DX (ODX)
Low Oncotype DX (ODX)
Low Oncotype DX (ODX) and low Bloom-Richardson (BR) grade
Lobular Carcinoma In Situ (LCIS)
Grade 4 cribriform
Grade 4 fused
Grade 4 glomeruloid
Grade 4 ill defined
Non-labelled tissue
Basal-like
Luminal A
Luminal B
Gleason Grade >=4
Non-atypical
Atypical ductal hyperplasia
Non-proliferative changes only
Prolifeerative changes
Gleason Grade 4 + Gleason Grade 5
Invasive Carcinoma of No Special Type (IC-NST)
No Invasive Carcinoma of No Special Type (IC-NST)
Non-neoplastic Pathological Brain tissue
ERG
Chromophobe renal cell carcinoma (KICH)
Clear cell renal cell carcinoma (KIRC)
Papillary renal cell carcinoma (KIRP)
Luminal breast cancer
Non-luminal breast cancer
Anemia
Adenomatous goiter
Medullary Thyroid Carcinoma (MTC)
Normal thyroid gland
Collagen Signatures
Uterine Corpus Endometrial Carcinoma (UCEC)
Spread Through Air Space
High-Grade Dysplasia
Low Risk Lesions (LRL)
Renal oncocytoma
AR
Endometrial Adenocarcinoma
Endometrial Polyp
Endometrial hyperplasia (EH)
Non-Chronic Lymphoblastic/Lymphocytic/Lymphoid Leukemia (CLL)
GLUT-1
Epidermis
Lymphoma (L)
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Intracranial Germinoma (IG)
Normal control
Mantle Cell Lymphoma (MCL)
Tumor Regression Grade 0
Tumor Regression Grade 1/2
Tumor Regression Grade 3
Peripheral Blood Mononuclear Cell (PBMC)
Muscularis Propria (MP)
Non-Muscularis Propria (MP)
Nerve tissue
Non-nerve tissue
High-grade
Low-grade
Inflammatory
Miscellaneous
Mild
Severe
Typical large-bowel biopsies
Latent membrane protein (LMP) 1 negative
Latent membrane protein (LMP) 1 positive
Macrophages
Chemo-sensitivity
High drug sensitivity
Low drug sensitivity
FOXP3
Gleason Grade 1-5
Gleason Grade >=6
Colorectal carcinoma
Silva Pattern
Multiple myeloma
Other hematological malignancies
Non-invasive
Double expressor negative
Double expressor positive
Non-adenoma
High risk
Low risk
Blood and lymphatic system
Digestive system
Female reproductive system
Respiratory system
High Ovarian Cancer Digital Pathology Index (OCDPI)
Low Ovarian Cancer Digital Pathology Index (OCDPI)
Microvascular invasion phenotypes
Biopsy and endoscopic resection
TMB
Nuclei
Primary CNS Lymphoma
Hematopoietic tissue
IgG4-ROD
Orbital MALT lymphoma
Non-viable tumor
Complete Response to Radiotherapy
No Complete Response to Radiotherapy
Neurofibroma
Perineurioma
Schwannoma
Amplified
Non-amplified
High-Grade Dysplasia (HGD)
Low-Grade Dysplasia (LGD)
Nondysplastic Barret Esophagus (NDBE)
Microsatellite Instability
Necrosis or Stroma
Atypical Glandular Cells (AGC)
Atypical Squamous Cells of Undetermined Significance (ASC-US)
Normal Cells
Abnormal Cells
Epithelial Cell Abnormalities Squamous Cells (ECA-SC)
Epithelial Cell Abnormalities Glandular Cells (ECA-GC)
Organisms
Nondysplastic Barrett esophagus (NDBE)
Melanocytic Density
Nasopharyngeal Carcinoma
Non-Nasopharyngeal Carcinoma
Adenocarcinoma In Situ (AIS)
Complex Gland
Micropappilary
Pappilary
Clean
Intramural Invasion
Benign inflamatory dermosis (BIDs)
Mycisis fungoids (MF)
Oncocytic Papillary Adenocarcinoma (OPA)
Non-Oncocytic Papillary Adenocarcinoma (N-OPA)
Tumor cells
Stromal cells
Pleomorphic adenoma (PA)
Myoepithelioma (MYO)
Warthin tumor (WT)
Basal cell adenoma (BCA)
Oncocytic adenoma (OA)
Cystadenoma (CST)
Mucoepidermoid carcinoma (MEC)
Salivary adenoid cystic carcinoma (SACC)
Normal (Norm)
Ki-67
Leukocytes
Pollution
Red blood cells
Lymphocytes
Low-immune
Mid-immune
Diploid
Aneuploid
Neutrophil
Eosinophil
Basophil
Lymphocyte
Monocyte
Immature granulocyte
Erythroblast
Platelet
Normal mucosa (NORM)
Stroma (STR)
Adipose tissue (ADI)
Normal lymph node tissue
Sessile Serrated Adenoma (SSA)
Hyperplastic Polyp (HP)
CDH1
PIK3CA
Dysplastic Epithelium
OED transformation risk
MLH1
PMS2
Mutation Density
Microsatellite Instability (MSI) high
Cervical Intraepithelial Neoplasia (CIN)
Genome Stable (GS)
Pleomorphism
Adipose (ADI)
Cancer-associated Stroma (STR)
Colorectal adenocarcinoma epithelium (TUM)
Non-dysplasia
IFTA
ARM
Fatty change
Hypertrophy
Increased mitosis
Proliferation
Extramedullary hematopoiesis
And Kidney Renal Papillary Cell Carcinoma (KIRP)
Lymphocytes (LYSM)
Wild Type
Tumour tissue (T)
Nontumour tissue (NT)
Lymph node (LN)
Biopsy and endoscopic resection (BE)
Immunohistochemistry (IHC)
Tissue microarray (TMA)
['Adipose (ADI)
Background (BACK)
Debris (DEB)
Lymphocytes (LYM)
Mucus (MUC)
Smooth muscle (MUS)
Normal colon mucosa (NORM)
Cancer-associated stroma (STR)
Colorectal adenocarcinoma epithelium (TUM)']
Consensus Molecular Subtypes (CMS)
Chromophobe
Renal papillary cell carcinoma (RPCC)
Kidney Renal Papillary Cell Carcinoma (KIRP)
Favorable
Poor
Present
Absence
Liver Hepatocellular Carcinoma (HCC)
Lung Squamous Cell Carcinoma (LSCC)
Renal Clear Cell Carcinoma (RCC)
Papillary Thyroid Carcinoma (PTC)
High-Grade Serous Carcinoma (HGSC)
Endometrioid Carcinoma (ENC)
Clear Cell Carcinoma (CCC)
Stage I
Stage II
Stage III
Stage IV
Stage Not Available
Serous Borderline Ovarian Tumor (SBOT)
High-grade Serous Ovarian Cancer (HGSOC)
Epithelial Mesenchymal Transition (EMT)
Kirsten Rat Sarcoma viral oncogene homolog (KRAS)
Tumor-Stroma Reaction (TSR)
Serous
Mucinous
Endometroid
Clear Cell
Non-Cancerous
No-recurrence
Effective
Invalid
Sensitive (responder)
Refractory (non-responder)
Favorable response
Poor response
Atypical
Ductal carcinoma in situ (DCIS)
Not Mutated
Carcinoid
Normal cells
Non-Squamous Cell Carcinoma (NSCC)
Small Cell Carcinoma
High-grade dysplasia (HGD)
Low-grade dysplasia (LGD)
Nondysplastic Barrett’s esophagus (NDBE)
Dysplastic
B-cell lymphoma
T-cell lymphoma
Basal
Luminal
Glandular
Pancreatic Ductal Adenocarcinoma (PDAC)
Subtype I
Subtype II
Subtype III
Sebaceous Gland Carcinoma (SGC)
Squamous Cell Carcinoma (SC)
CIN2+
Melanoma
Nevus
Sjögren's syndrome
Colon Adenocarcinoma
Benign Colonic Tissue
Lung Adenocarcinoma
Lung Squamous Cell Carcinoma
Benign Lung Tissue
Lymph node metastasis
Basaloid cell
Ghost cell
Other cell
Follicular Adenoma
Follicular Thyroid Carcinoma recurrence
Vascular Invasion
Wide Capsular Invasion
Non-invasive Epithelial Superficial Region
Submucosal Invasive Region
Early recurrence
CD8
CD4
Tumor aggressiveness grade
M2 macrophage infiltration
Intraepithelial neoplasia
Polyp
M2-subtype tumor-associated macrophage density
Gleason grades
Nondiagnostic
Follicular neoplasm
No recurrence
Adenosis
Fibroadenoma
Phyllodes tumor
Tubular adenoma
Ductal carcinoma
Lobular carcinoma
Mucinous carcinoma
Papillary carcinoma
Benign colon tissue
Colon adenocarcinomas
Intrahepatic Cholangiocarcinoma
Combined Hepatocellular-Cholangiocarcinoma
Relapse
No relapse
Alveoli
Background
ESCC-pathomics signature
MGMT promoter
Odontogenic Keratocyst (OKC)
Orthokeratinized Odontogenic Cyst (OOC)
Gorlin Syndrome (GS)
Tertiary lymphoid structures (TLSs)
Invasive Ductal Carcinoma
Platinum sensitive
Refractory/resistive